Northern Trust Corp Genmab A/S Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Genmab A/S stock. As of the latest transaction made, Northern Trust Corp holds 504,523 shares of GMAB stock, worth $10.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

504,523

Previous 519,384 2.86%

Holding current value

$10.4 Million

Previous $13.1 Million 5.76%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$23.84 - $28.48 $354,286 - $423,241	-14,861 Reduced 2.86%	504,523 $12.3 Million
Q2 2024 Aug 14, 2024	SELL	$25.13 - $30.27 $875,629 - $1.05 Million	-34,844 Reduced 6.29%	519,384 $13.1 Million
Q1 2024 May 14, 2024	BUY	$26.43 - $32.77 $401,683 - $498,038	15,198 Added 2.82%	554,228 $16.6 Million
Q4 2023 Feb 13, 2024	SELL	$27.94 - $35.44 $559,191 - $709,296	-20,014 Reduced 3.58%	539,030 $17.2 Million
Q3 2023 Nov 13, 2023	BUY	$35.27 - $42.24 $8.96 Million - $10.7 Million	254,042 Added 83.29%	559,044 $19.7 Million
Q2 2023 Aug 11, 2023	BUY	$37.4 - $42.94 $123,719 - $142,045	3,308 Added 1.1%	305,002 $11.6 Million
Q1 2023 May 15, 2023	SELL	$34.88 - $43.22 $116,638 - $144,527	-3,344 Reduced 1.1%	301,694 $11.4 Million
Q4 2022 Feb 13, 2023	SELL	$33.8 - $47.06 $862,812 - $1.2 Million	-25,527 Reduced 7.72%	305,038 $12.9 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $646,601 - $7.66 Million	20,514 Added 6.62%	330,565 $10.6 Million
Q2 2022 Aug 12, 2022	SELL	$26.83 - $38.57 $19,317 - $27,770	-720 Reduced 0.23%	310,051 $10.1 Million
Q1 2022 May 13, 2022	SELL	$30.95 - $39.68 $134,075 - $171,893	-4,332 Reduced 1.37%	310,771 $11.2 Million
Q4 2021 Feb 08, 2022	BUY	$35.87 - $47.12 $196,388 - $257,982	5,475 Added 1.77%	315,103 $12.5 Million
Q3 2021 Nov 15, 2021	SELL	$41.55 - $48.72 $2.49 Million - $2.92 Million	-59,865 Reduced 16.2%	309,628 $13.5 Million
Q2 2021 Aug 13, 2021	SELL	$32.88 - $44.57 $6.89 Million - $9.34 Million	-209,474 Reduced 36.18%	369,493 $15.1 Million
Q1 2021 May 12, 2021	BUY	$30.92 - $44.4 $8.17 Million - $11.7 Million	264,230 Added 83.95%	578,967 $19 Million
Q4 2020 Feb 11, 2021	BUY	$33.66 - $40.76 $510,891 - $618,655	15,178 Added 5.07%	314,737 $12.8 Million
Q3 2020 Nov 16, 2020	BUY	$33.07 - $38.68 $254,407 - $297,565	7,693 Added 2.64%	299,559 $11 Million
Q2 2020 Aug 14, 2020	BUY	$20.05 - $33.89 $14,716 - $24,875	734 Added 0.25%	291,866 $9.89 Million
Q1 2020 May 14, 2020	BUY	$17.15 - $25.22 $2.95 Million - $4.34 Million	171,934 Added 144.24%	291,132 $6.17 Million
Q4 2019 Feb 14, 2020	BUY	$18.88 - $24.14 $1.04 Million - $1.33 Million	55,069 Added 85.87%	119,198 $2.66 Million
Q3 2019 Nov 13, 2019	BUY	$18.0 - $21.38 $1.15 Million - $1.37 Million	64,129 New	64,129 $1.3 Million

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Genmab A/S Transaction History